Neuroblastoma is relatively likely to be a malignant tumor, typically characterized by rapid growth of malignant tumors.

In the early stages of the disease, it often adheres to surrounding tissues, making it difficult to completely remove through surgery. Even with surgical treatment, the outcomes are generally modest, and recurrence is likely to occur shortly after surgery. Once recurrence occurs, the malignancy of the tumor will continue to increase.

For these patients, the prognosis is poor. It is generally recommended to undergo surgical treatment early, followed by radiotherapy and chemotherapy to potentially extend the patient's lifespan, but it is usually difficult to cure.